首页>
外国专利>
USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION
USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION
展开▼
机译:在急性心肌梗死的第一反应中使用核糖
展开▼
页面导航
摘要
著录项
相似文献
摘要
D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen-free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour.
展开▼
机译:D-核糖用于在急救期间遭受急性心肌梗塞的患者,以防止心脏损害。在那些能够摄入液体的患者中,口服2至5克D-核糖。在无法摄入液体的患者中,或在静脉输液的患者中,无热原的D-核糖以50-300 mg / kg /小时的速度静脉内给药。
展开▼